GlobalData forecasts predict Enhertu will retain its dominant market position in...
Oncternal is halting the development of two cancer candidates, ONCT-534 and ONCT...
The company plans to focus its resources on conducting clinical trials for CD388...
Sobi and Enable Injections have entered an agreement for the development and dis...
The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza...
R&D frameworks are in place for the next pandemic-causing pathogen, but ways to ...
Sanofi has signed a licensing agreement with RadioMedix and Orano Med to advance...
Lilly has announced a significant expansion of its manufacturing presence in Ire...
Moderna will slash five clinical programmes but says it remains on track for ten...
The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficac...
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a...
Sanofi has announced the inauguration its new modular vaccine and biomedicine pr...
Gilead Sciences has partnered with Genesis Therapeutics to discover and develop ...
As the approval date for Bristol Myers Squibb’s schizophrenia drug KarXT looms, ...
The FDA has granted breakthrough therapy designation to Neuraptive Therapeutics’...
Johnson & Johnson has announced that the US FDA has approved TREMFYA for the tre...
